Pursuant to section 20 of the Medicines Act 1981 (“Act”), the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Solifenacin Mylan
Solifenacin succinate 5mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Aurangabad, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Solifenacin Mylan
Solifenacin succinate 10mg
Film coated tablet
Mylan New Zealand Limited
Mylan Laboratories Limited, Aurangabad, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Utrogestan
Progesterone 200mg
Capsule
Pharmaco (NZ) Limited
Cyndea Pharma S.L., Soria, Spain
Olic (Thailand) Limited, Ayutthaya, Thailand
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Utrogestan
Progesterone 100mg
Capsule
Pharmaco (NZ) Limited
Cyndea Pharma S.L., Soria, Spain
Olic (Thailand) Limited, Ayutthaya, Thailand
|
Dated this 16th day of March 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz